Author: chc

10/24/2011

RPM Report: Pandora’s Box Officially Open as New Legal Challenges to FDA’s Off-label Restrictions Emerge

10/18/2011

Par Pharma Case Asserts That First Amendment Protects Truthful Off-label Speech

10/14/2011

CHC Executive Director Criticizes EU Ban on DTC

10/11/2011

Proposal Calls for More Transparency for FDA Enforcement Data

10/04/2011

CMS Misses Sunshine Act Rule Deadline

10/03/2011

Pitts on the Politics of Drug Industry Sponsorship

09/29/2011

Kamp on the Sunshine Act: Collaboration Key to Patient Care

09/21/2011

Patients Need Education on Value of New Drugs

09/19/2011

DDMAC Reorganized into Office of Prescription Drug Promotion